Pregnancy outcome after exposure to the novel oral anticoagulant rivaroxaban in women at suspected risk for thromboembolic events: a case series from the German Embryotox Pharmacovigilance Centre.
about
Current challenges and future prospects in oral anticoagulant therapy.Atrial fibrillation in pregnancy: a growing challenge.The prevention and treatment of venous thromboembolism in pregnancy.[Pharmacovigilance in Germany : It is about time].Management of direct oral anticoagulants in women of childbearing potential: guidance from the SSC of the ISTH.Challenges of Anticoagulation Therapy in Pregnancy.Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants.
P2860
Q38675822-A915AD91-CE4C-4D96-AE93-25F9D2793DB2Q38789706-A225096C-3468-4DCA-B528-A81CCA25313DQ39251751-530AA0F3-A391-40D2-A202-81A595490964Q40736061-0289285D-91FD-40C4-AF0A-0AC025D24026Q45855603-82467B22-AA0D-48B4-9E44-F1A9127B14F9Q47252275-F9EB8703-CCB6-464B-B060-CDCA1026325CQ49647319-EAC614B4-9A0F-4E81-9B96-8FDA4BBBFEFE
P2860
Pregnancy outcome after exposure to the novel oral anticoagulant rivaroxaban in women at suspected risk for thromboembolic events: a case series from the German Embryotox Pharmacovigilance Centre.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pregnancy outcome after exposu ...... otox Pharmacovigilance Centre.
@en
type
label
Pregnancy outcome after exposu ...... otox Pharmacovigilance Centre.
@en
prefLabel
Pregnancy outcome after exposu ...... otox Pharmacovigilance Centre.
@en
P2093
P2860
P921
P1476
Pregnancy outcome after exposu ...... otox Pharmacovigilance Centre.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00392-015-0893-5
P577
2015-07-21T00:00:00Z